Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments. (2016)

First Author: Fisusi FA
Attributed to:  The delivery of 150 kDa antibodies to the brain funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11095-016-1872-x

PubMed Identifier: 26903051

Publication URI: http://europepmc.org/abstract/MED/26903051

Type: Journal Article/Review

Volume: 33

Parent Publication: Pharmaceutical research

Issue: 5

ISSN: 0724-8741